(19)
(11) EP 4 412 636 A2

(12)

(88) Date of publication A3:
03.08.2023

(43) Date of publication:
14.08.2024 Bulletin 2024/33

(21) Application number: 22859187.1

(22) Date of filing: 12.09.2022
(51) International Patent Classification (IPC): 
A61K 38/21(2006.01)
C07K 16/28(2006.01)
A61P 31/12(2006.01)
C07K 14/56(2006.01)
A61K 47/68(2017.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 14/56; C07K 2319/33; A61K 38/00; C07K 2317/76; C07K 16/2827; A61K 2039/505
(86) International application number:
PCT/US2022/040807
(87) International publication number:
WO 2023/023283 (23.02.2023 Gazette 2023/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 01.06.2022 US 202263347871 P

(71) Applicant: REMD Biotherapeutics, Inc.
Camarillo, California 93012 (US)

(72) Inventors:
  • YAN, Hai
    Thousand Oaks, CA 91320 (US)
  • WANG, Wuyi
    Newbury Park, CA 91320 (US)
  • STEWARD, Kristopher
    Newbury Park, CA 91320 (US)

(74) Representative: Boynton, Juliette Alice et al
Schlich 9 St. Catherine's Road
Littlehampton, West Sussex BN17 5HS
Littlehampton, West Sussex BN17 5HS (GB)

   


(54) NOVEL INTERFERON VARIANTS AND BIFUNCTIONAL FUSION MOLECULES THEREOF